The PI3K/AKT/mTOR pathway favors HCC development by promoting neovascularization via HIF-1α and vascular endothelial growth factor (VEGF) upregulated expression and by promoting tumor invasion, metastasis and cell cycle progression [95,96]. Here, MTOR is linked to hepatocellular carcinoma.